Skip to content

In Vivo Imaging of Therapeutic Electric Current Flow

In Vivo Imaging of Therapeutic Electric Current Flow

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02453763
Acronym
tDCS
Enrollment
17
Registered
2015-05-25
Start date
2015-06-30
Completion date
2017-07-06
Last updated
2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease, Autism, Depression, Epilepsy, Parkinson Disease, Schizophrenia, Stroke

Keywords

Transcranial direct current stimulation, Noninvasive brain stimulation, Brain, Central Nervous System Diseases, Nervous System Diseases, Parkinson disease, Stroke, Epilepsy, Depression, Schizophrenia, Brain imaging, Electrical impedance tomography, Magnetic resonance electrical impedance tomography, Diffusion tensor imaging, Functional magnetic imaging, Rehabilitation

Brief summary

The purpose of this research study is to measure current flow inside the head using magnetic resonance imaging (MRI). The data from this study will be used to map the current flow caused from the electrical stimulation inside the head. The methods develop will be used to map and better control delivery of the current for electrical stimulation to modify a psychiatric condition such as depression; or other conditions such as epilepsy, Parkinson's disease or autism.

Detailed description

Transcranial direct current stimulation (tDCS) and deep brain stimulation (DBS) are examples of electrical stimulation therapies that are rapidly gaining attention as means of modulating motor function, semantic processing, and executive function. Both therapies have attracted many clinical and experimental studies. tDCS has been found to have both facilitatory and inhibitory effects on the brain depending on stimulation polarity and electrode position. DBS has been thoroughly evaluated clinically for treatment of movement disorders, principally Parkinson's disease, and is extending its reach to include treatment of disorders such as focal dystonia, depression and chronic pain. While still mostly in the experimental stage, tDCS applications and acceptance are growing extremely rapidly. Although the functional alterations associated with tDCS can be categorized without knowledge of the underlying neurophysiology, an understanding of where externally applied current actually flows in any electrical stimulation technique is crucial as a basis for understanding which brain regions, circuits, or elements are affected by these therapies, and how these changes may occur. Such knowledge will lead to a better understanding of the mechanisms underlying these therapies, and thus to more focused and effective stimulation patterns and locations. Ultimately, this will lead to more efficient and novel clinical applications. Many studies have simulated the effects of current application in both extra- and intracranial modalities using computer simulation. Simulations will always be limited by errors in interpreting MRI data during segmentation, differences between assumed and actual electrical conductivity values, and mismatches between actual and presumed electrode locations and sizes. Thus, better methods to understand and verify current flow distributions are badly needed. In this study a recently developed MRI-based phase imaging technique to more directly measure current densities in vivo. Unlike earlier MRI-based methods of measuring electrical current flow, the technique works without requiring subject repositioning. This methods will be validated against high-resolution subject-specific models incorporating many tissue compartments, including anisotropic white matter. Thus, a new direct measurement method against state-of-the-art modeling approaches.

Interventions

DEVICETranscranial direct current stimulation

All participants will receive transcranial direct current stimulation. During the MRI images of the head a battery-powered device pulses a small current between a pair of the electrodes which will be immediately followed by more MRI images. The current pulses will be very short and there should be no feeling from the pulses. The entire imaging period will be at most 90 minutes.

PROCEDUREMRI

All participants will receive an MRI. During the MRI images of the head a battery-powered device pulses a small current between a pair of the electrodes which will be immediately followed by more MRI images. The current pulses will be very short and there should be no feeling from the pulses. The entire imaging period will be at most 90 minutes.

Sponsors

Arizona State University
CollaboratorOTHER
National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* right handed (as determined by the Edinburgh battery), * English as native language.

Exclusion criteria

* appreciable deficits in hearing, * appreciable problems with articulation, * appreciable accent schizophrenia, bipolar disorder, or major depression, * any neurological disorder associated with cognitive impairment or neuroanatomic abnormality, * language-based learning disorder, * any implanted metal device (precludes use of tDCS), any implanted cardiac pacemaker, * dementia or mini-mental state exam, * \<24 estimated verbal intelligence, * \<70 active or prior history of seizure disorder, family history of seizure disorder, prescribed seizure inducing medication.

Design outcomes

Primary

MeasureTime frameDescription
Magnetic Resonance Imaging (MRI) of therapeutic current flowDay 1The MRI will be used to measure current flow in the brain as a result of therapeutic electrical stimulation techniques by using a recently developed MRI-based phase imaging technique to more directly measure current densities in vivo.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026